JDRESS LTD
Company number 15207118 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
JDRESS LTD - Analysis Report
Company Number: 15207118
Analysis Date: 2025-07-29 20:58 UTC
Financial Health Assessment Report for JDRESS LTD
1. Financial Health Score: D
Explanation:
JDRESS LTD’s financial health score is graded as D due to its negative net assets position and minimal working capital, despite being a very young company. The financial statements show a marginal positive total assets less current liabilities figure (£613) but an overall negative net assets/shareholders’ funds of (£17). This indicates early-stage financial stress or undercapitalization, which is common in start-ups but still a cautionary sign that requires close management.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 8,688 | Indicates liquid resources such as cash or receivables available in the short term. |
| Current Liabilities | 8,075 | Short-term debts due within one year, almost equal to current assets, limiting liquidity. |
| Net Current Assets (Working Capital) | 613 | Positive but very thin margin; a narrow cushion to cover short-term obligations. |
| Accruals and Deferred Income | 630 | Obligations or income recognition timing differences, slightly larger than net current assets. |
| Net Assets / Shareholders Funds | -17 | Negative equity position implies liabilities slightly exceed total assets after accounting for accruals. |
Additional Notes:
- The company employs 2 people, including a director, indicating small operational scale.
- Financial statements prepared under the micro-entity regime, which limits reporting detail.
- No profit and loss account filed, so profitability and cash flow analysis is unavailable.
- The company is active and not in liquidation but has overdue confirmation statement filings (governance compliance risk).
3. Diagnosis
JDRESS LTD exhibits symptoms of financial fragility commonly seen in start-up or newly incorporated entities:
- Thin liquidity buffer: Current assets just cover current liabilities, indicating a "healthy cash flow" is not yet established. The company may face challenges meeting short-term obligations if cash inflows do not materialize promptly.
- Negative net assets: A slight negative equity position suggests initial funding might have been insufficient or that early expenses have eroded capital. This is a warning signal of undercapitalization.
- Lack of profitability data: Without profit and loss statements, it’s unclear if the business is generating income or operating at a loss; this opacity is a risk factor.
- Governance compliance: Overdue confirmation statement filing could attract penalties and reflects potential administrative neglect, which can affect credibility with suppliers and investors.
Overall, JDRESS LTD is in a precarious but not critical state—it is still in early stages of development, and the financials reflect a “pre-illness” phase where early interventions can prevent deterioration.
4. Recommendations
To improve financial wellness and ensure the company’s viability, the following actions are advised:
- Strengthen working capital: Consider raising additional equity or short-term financing to create a more comfortable liquidity buffer beyond the current £613.
- Improve financial reporting: Submit overdue confirmation statements promptly to maintain compliance and avoid fines or reputational damage.
- Establish profitability metrics: Begin detailed tracking of income and expenses to understand operational performance and cash flow dynamics.
- Cost control and cash management: Tighten expenditure and closely monitor receivables/payables to prevent cash flow distress.
- Strategic review: Evaluate business model viability and sales pipeline to ensure growth prospects justify ongoing investment.
- Engage professional advice: Regular review by accountants or financial advisors can help diagnose early financial symptoms and prescribe targeted remedies.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.